2409TiP A global, multicentre, open-label, randomised phase II trial of tobemstomig (tobe) with or without tiragolumab (tira) vs atezolizumab (atezo) in patients (pts) with untreated metastatic urothelial cancer (mUC) ineligible for platinum-based chemotherapy (chemo)
Gupta, S., Alhalabi, O., Bamias, A., Bellmunt, J., Castellano Gauna, D.E., Bedke, J., Friedlander, T., Garmezy, B., Grivas, P., Huddart, R.A., Necchi, A., Powles, T.B., Puente, J., Da Rosa, D.A.R., Wang, F., Lambertini, C., Andreev-Drakhlin, A., Fasso, M., Loriot, Y.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article